Islet cell autoantibodies: a case of a premature obituary
- 1 December 2005
- journal article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 6 (4) , 181-183
- https://doi.org/10.1111/j.1399-543x.2005.00128.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodiesPediatric Diabetes, 2005
- Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 2003
- Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.Diabetes, 1999
- Validity of Screening for Individuals at Risk for Type I Diabetes by Combined Analysis of Antibodies to Recombinant ProteinsDiabetes Care, 1997
- Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDMJournal of Clinical Endocrinology & Metabolism, 1995
- Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivityDiabetologia, 1995
- Do Glutamic Acid Decarboxylase Antibodies Improve the Prediction of IDDM in First-degree Relatives At Risk for IDDM?Journal of Autoimmunity, 1994
- Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive RelativesDiabetes, 1994